Cargando…
Continuous evolution of SpCas9 variants compatible with non-G PAMs
The targeting scope of Streptococcus pyogenes Cas9 (SpCas9) and its engineered variants is largely restricted to protospacer-adjacent motif (PAM) sequences containing Gs. Here, we report the evolution of three new SpCas9 variants that collectively recognize NRNH PAMs (where R = A or G and H = A, C,...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145744/ https://www.ncbi.nlm.nih.gov/pubmed/32042170 http://dx.doi.org/10.1038/s41587-020-0412-8 |
_version_ | 1783520048464265216 |
---|---|
author | Miller, Shannon M. Wang, Tina Randolph, Peyton B. Arbab, Mandana Shen, Max W. Huang, Tony P. Matuszek, Zaneta Newby, Gregory A. Rees, Holly A. Liu, David R. |
author_facet | Miller, Shannon M. Wang, Tina Randolph, Peyton B. Arbab, Mandana Shen, Max W. Huang, Tony P. Matuszek, Zaneta Newby, Gregory A. Rees, Holly A. Liu, David R. |
author_sort | Miller, Shannon M. |
collection | PubMed |
description | The targeting scope of Streptococcus pyogenes Cas9 (SpCas9) and its engineered variants is largely restricted to protospacer-adjacent motif (PAM) sequences containing Gs. Here, we report the evolution of three new SpCas9 variants that collectively recognize NRNH PAMs (where R = A or G and H = A, C, or T) using phage-assisted non-continuous evolution (PANCE), three new phage-assisted continuous evolution (PACE) strategies for DNA binding, and a secondary selection for DNA cleavage. The targeting capabilities of these evolved variants and SpCas9-NG were characterized in HEK293T cells using a library of 11,776 genomically integrated protospacer-sgRNA pairs containing all possible NNNN PAMs. The evolved variants mediate indel formation and base editing in human cells and enable the A•T-to-G•C base editing of a sickle-cell anemia mutation using a previously inaccessible CACC PAM. These new evolved SpCas9s, together with previously reported variants, in principle enable targeting the majority of NR PAM sequences and substantially reduce the fraction of genomic sites that are inaccessible by Cas9-based methods. |
format | Online Article Text |
id | pubmed-7145744 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71457442020-08-10 Continuous evolution of SpCas9 variants compatible with non-G PAMs Miller, Shannon M. Wang, Tina Randolph, Peyton B. Arbab, Mandana Shen, Max W. Huang, Tony P. Matuszek, Zaneta Newby, Gregory A. Rees, Holly A. Liu, David R. Nat Biotechnol Article The targeting scope of Streptococcus pyogenes Cas9 (SpCas9) and its engineered variants is largely restricted to protospacer-adjacent motif (PAM) sequences containing Gs. Here, we report the evolution of three new SpCas9 variants that collectively recognize NRNH PAMs (where R = A or G and H = A, C, or T) using phage-assisted non-continuous evolution (PANCE), three new phage-assisted continuous evolution (PACE) strategies for DNA binding, and a secondary selection for DNA cleavage. The targeting capabilities of these evolved variants and SpCas9-NG were characterized in HEK293T cells using a library of 11,776 genomically integrated protospacer-sgRNA pairs containing all possible NNNN PAMs. The evolved variants mediate indel formation and base editing in human cells and enable the A•T-to-G•C base editing of a sickle-cell anemia mutation using a previously inaccessible CACC PAM. These new evolved SpCas9s, together with previously reported variants, in principle enable targeting the majority of NR PAM sequences and substantially reduce the fraction of genomic sites that are inaccessible by Cas9-based methods. 2020-02-10 2020-04 /pmc/articles/PMC7145744/ /pubmed/32042170 http://dx.doi.org/10.1038/s41587-020-0412-8 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Miller, Shannon M. Wang, Tina Randolph, Peyton B. Arbab, Mandana Shen, Max W. Huang, Tony P. Matuszek, Zaneta Newby, Gregory A. Rees, Holly A. Liu, David R. Continuous evolution of SpCas9 variants compatible with non-G PAMs |
title | Continuous evolution of SpCas9 variants compatible with non-G PAMs |
title_full | Continuous evolution of SpCas9 variants compatible with non-G PAMs |
title_fullStr | Continuous evolution of SpCas9 variants compatible with non-G PAMs |
title_full_unstemmed | Continuous evolution of SpCas9 variants compatible with non-G PAMs |
title_short | Continuous evolution of SpCas9 variants compatible with non-G PAMs |
title_sort | continuous evolution of spcas9 variants compatible with non-g pams |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145744/ https://www.ncbi.nlm.nih.gov/pubmed/32042170 http://dx.doi.org/10.1038/s41587-020-0412-8 |
work_keys_str_mv | AT millershannonm continuousevolutionofspcas9variantscompatiblewithnongpams AT wangtina continuousevolutionofspcas9variantscompatiblewithnongpams AT randolphpeytonb continuousevolutionofspcas9variantscompatiblewithnongpams AT arbabmandana continuousevolutionofspcas9variantscompatiblewithnongpams AT shenmaxw continuousevolutionofspcas9variantscompatiblewithnongpams AT huangtonyp continuousevolutionofspcas9variantscompatiblewithnongpams AT matuszekzaneta continuousevolutionofspcas9variantscompatiblewithnongpams AT newbygregorya continuousevolutionofspcas9variantscompatiblewithnongpams AT reeshollya continuousevolutionofspcas9variantscompatiblewithnongpams AT liudavidr continuousevolutionofspcas9variantscompatiblewithnongpams |